share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
美股sec公告 ·  07/16 16:28
Moomoo AI 已提取核心訊息
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
2024年7月12日,與eyepoint pharmaceuticals有關的David R. Guyer完成了一系列公司普通股相關的交易。Guyer通過行權或轉換衍生證券獲得了總共9,775股,股價在3.26美元到3.50美元之間。隨後,Guyer以每股10.0641美元的價格在公開市場上出售了11,625股。這些交易之後,Guyer在eyepoint pharmaceuticals的直接持股減少到了1,850股。出售的股份總市值約爲116,995.16美元。
2024年7月12日,與eyepoint pharmaceuticals有關的David R. Guyer完成了一系列公司普通股相關的交易。Guyer通過行權或轉換衍生證券獲得了總共9,775股,股價在3.26美元到3.50美元之間。隨後,Guyer以每股10.0641美元的價格在公開市場上出售了11,625股。這些交易之後,Guyer在eyepoint pharmaceuticals的直接持股減少到了1,850股。出售的股份總市值約爲116,995.16美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息